<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_dCunp6e">Clinical impact and quality of randomized controlled trials involving interventions evaluating artificial intelligence prediction tools: a systematic review</title>
				<funder ref="#_MACAbUm">
					<orgName type="full">Medical Scientific Research Foundation of Guangdong Province of China</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Qian</forename><surname>Zhou</surname></persName>
							<idno type="ORCID">0000-0003-3954-5449</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medical Statistics , Clinical Trials Unit , The First Affiliated Hospital of Sun Yat-sen University , 58 Zhong Shan Er Road , 510080 Guangzhou , China.</note>
								<orgName type="department">Department of Medical Statistics</orgName>
								<orgName type="laboratory">Clinical Trials Unit</orgName>
								<orgName type="institution">The First Affiliated Hospital of Sun Yat-sen University</orgName>
								<address>
									<addrLine>58 Zhong Shan Er Road</addrLine>
									<postCode>510080</postCode>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhi-Hang</forename><surname>Chen</surname></persName>
							<idno type="ORCID">0000-0003-3927-7069</idno>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Liver Surgery , The First Affiliated Hospital , Sun Yat-sen</note>
								<orgName type="department">Department of Liver Surgery</orgName>
								<orgName type="institution">The First Affiliated Hospital</orgName>
								<address>
									<addrLine>Sun Yat-sen</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yi-Heng</forename><surname>Cao</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medical Statistics , Clinical Trials Unit , The First Affiliated Hospital of Sun Yat-sen University , 58 Zhong Shan Er Road , 510080 Guangzhou , China.</note>
								<orgName type="department">Department of Medical Statistics</orgName>
								<orgName type="laboratory">Clinical Trials Unit</orgName>
								<orgName type="institution">The First Affiliated Hospital of Sun Yat-sen University</orgName>
								<address>
									<addrLine>58 Zhong Shan Er Road</addrLine>
									<postCode>510080</postCode>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sui</forename><surname>Peng</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> University , 510080 Guangzhou , China. Clinical Trials Unit ,</note>
								<orgName type="laboratory">Clinical Trials Unit</orgName>
								<orgName type="institution">University</orgName>
								<address>
									<postCode>510080</postCode>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>4</label> University , 510080 Guangzhou , China. Department of Gastroenterology ,</note>
								<orgName type="department">Department of Gastroenterology</orgName>
								<orgName type="institution">University</orgName>
								<address>
									<postCode>510080</postCode>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">The First Affiliated Hospital , Sun Yat-sen</note>
								<orgName type="institution">The First Affiliated Hospital</orgName>
								<address>
									<addrLine>Sun Yat-sen</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">The First Affiliated Hospital , Sun Yat</note>
								<orgName type="institution">The First Affiliated Hospital</orgName>
								<address>
									<addrLine>Sun Yat</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">-sen University , 510080 Guangzhou , China.</note>
								<orgName type="institution">-sen University</orgName>
								<address>
									<postCode>510080</postCode>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_Y3Wj7tS">Clinical impact and quality of randomized controlled trials involving interventions evaluating artificial intelligence prediction tools: a systematic review</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">A0AF3DE53A085DA9A3C8FADF0CB195B4</idno>
					<idno type="DOI">10.1038/s41746-021-00524-2</idno>
					<note type="submission">Received: 7 April 2021; Accepted: 30 September 2021;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:02+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_a8A5DeJ"><p xml:id="_fhQ8n4R"><s xml:id="_T8CShUS">The evidence of the impact of traditional statistical (TS) and artificial intelligence (AI) tool interventions in clinical practice was limited.</s><s xml:id="_2Psmwx9">This study aimed to investigate the clinical impact and quality of randomized controlled trials (RCTs) involving interventions evaluating TS, machine learning (ML), and deep learning (DL) prediction tools.</s><s xml:id="_GGfK4vS">A systematic review on PubMed was conducted to identify RCTs involving TS/ML/DL tool interventions in the past decade.</s><s xml:id="_bN2AZDB">A total of 65 RCTs from 26,082 records were included.</s><s xml:id="_yJdE2pf">A majority of them had model development studies and generally good performance was achieved.</s><s xml:id="_xsU8N45">The function of TS and ML tools in the RCTs mainly included assistive treatment decisions, assistive diagnosis, and risk stratification, but DL trials were only conducted for assistive diagnosis.</s><s xml:id="_USN5jFM">Nearly two-fifths of the trial interventions showed no clinical benefit compared to standard care.</s><s xml:id="_cKS6asV">Though DL and ML interventions achieved higher rates of positive results than TS in the RCTs, in trials with low risk of bias (17/65) the advantage of DL to TS was reduced while the advantage of ML to TS disappeared.</s><s xml:id="_bDM9qGD">The current applications of DL were not yet fully spread performed in medicine.</s><s xml:id="_QsGmEYc">It is predictable that DL will integrate more complex clinical problems than ML and TS tools in the future.</s><s xml:id="_vRdxs27">Therefore, rigorous studies are required before the clinical application of these tools.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AtncrSm">INTRODUCTION</head><p xml:id="_8947hDF"><s xml:id="_gmvFZH5">An abundance of prediction tools in medicine has been developed and validated to support health decision-making.</s><s xml:id="_4DZeg6y">Prediction tools usually use several predictors to estimate the probability of individuals' present disease or predict specific situations or events in the future <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref> .</s><s xml:id="_DkFfEW3">Conventionally, prediction tools are constructed by statistical regression models based on structured patients' clinical data <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> .</s><s xml:id="_NvNcCAR">The recent development of computer technology facilitates the application of machine learning (ML) and even deep learning (DL) algorithms which is a subset of ML in the establishment of prediction tools <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref> .</s><s xml:id="_qSUvdRU">In contrast to conventional prediction tools, ML-or DL-based prediction tools which are both subsets of artificial intelligence (AI) technology usually use data with high-dimensional features, medical images, or even videos to develop models <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> .</s><s xml:id="_qnmp5E9">Many observational studies of model development and validation showed that ML prediction tools performed better than traditional statistical (TS) models in the prediction of disease diagnosis and prognosis by showing higher values of area under the receiver operating characteristic curve (AUC) or accuracy <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> .</s><s xml:id="_gg2NYRG">Others found that DL models outperformed standard ML <ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19</ref> .</s><s xml:id="_RqchNtQ">Some of the DL prediction tools have achieved expertise level of diagnostic accuracy in several aspects of diseases <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref> .</s><s xml:id="_reYtHsa">Many reports claimed that a welldeveloped AI prediction tool with adequate performance could assist or even replace clinicians in treatment strategy making for patients' care <ref type="bibr" target="#b10">11</ref> .</s></p><p xml:id="_f2RsnGJ"><s xml:id="_PRwavGZ">However, some observational studies found that ML prediction algorithms did not outperform TS models for binary outcomes <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> , while DL did not always perform better than ML in model development and/or validation studies <ref type="bibr" target="#b24">25</ref> .</s><s xml:id="_AwH6AhS">More importantly, the clinical effectiveness of these prediction tools based on both traditional and advanced technology for clinical application remains controversial <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> .</s><s xml:id="_T6Ywp9h">Randomized controlled trials (RCTs) are considered to be the gold standard to establish whether using a prediction tool provides an improvement in the management of patients compared to not using the tool <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> .</s><s xml:id="_SAWRqpe">This kind of design played an important role in providing highquality evidence in evidence-based medicine in the past decades <ref type="bibr" target="#b31">32</ref> .</s><s xml:id="_GabXSKp">In prediction model research, more and more RCTs involving interventions evaluating TS, ML, and DL tools were published to evaluate the efficacy of a prediction model compared to clinical standard care.</s><s xml:id="_XERVwgG">The primary outcomes of these RCTs evaluating prediction tools were not patient outcomes which were often difficult to change but other outcomes such as decisionmaking <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34</ref> , behavior change <ref type="bibr" target="#b34">35</ref> , cost-effectiveness <ref type="bibr" target="#b35">36</ref> etc.</s><s xml:id="_KPntVvk">Some of these studies showed that prediction models did not show good clinical benefit in clinical application level <ref type="bibr" target="#b36">37</ref> .</s><s xml:id="_Ze4M47D">Previous studies have reviewed RCTs evaluating AI interventions in digital health and medical decision support systems, suggesting that the evidence of the effectiveness of AI interventions is limited and contradictory, and their quality is variable <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> .</s><s xml:id="_NR5rK8N">However, the included studies in these reviews were of small number and in specific fields, and little quantitative analysis was made.</s></p><p xml:id="_rcJ4jcW"><s xml:id="_x53KgYg">With the increasing number of RCTs evaluating the clinical effectiveness of AI tools recently, concerns about study design and reporting have been raised as well.</s><s xml:id="_e636yhf">The Consolidated Standards of Reporting Trials (CONSORT) statement is a 37-item checklist for reporting randomized trials and is widely used in medical research <ref type="bibr" target="#b39">40</ref> .</s><s xml:id="_WMP7Jwc">With the growing recognition of rigorous evaluation for reporting AI trials, the CONSORT statement was planned to adapt to account for specific considerations for AI interventional studies <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42</ref> .</s><s xml:id="_fHT2ET7">The CONSORT-AI extension has been published recently, which is a 37-item checklist for reporting randomized trials evaluating AI interventions but included 14 new items that are specific for AI interventional trials <ref type="bibr" target="#b41">42</ref> .</s><s xml:id="_Y4aGur2">Therefore, understanding the clinical effectiveness and quality of these RCTs can provide a reference for more such studies in the future, and vice versa, it may inform future research in model development and application in the early phases of model construction as well.</s></p><p xml:id="_fSnw6MC"><s xml:id="_aHWReyf">In this review, we aimed to conduct research of published literature of RCTs involving interventions of traditional statistical or artificial intelligence (TS/AI) prediction tools.</s><s xml:id="_3UpXJ3a">First, the quality of these RCTs was evaluated through the Cochrane risk-of-bias tool <ref type="bibr" target="#b42">43</ref> .</s><s xml:id="_4M5UVMs">Second, the clinical effectiveness of these prediction tools was evaluated according to the main findings of the trial and compared with its previous observational studies of model development and validation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jMmUnPU">METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CdrQjJa">Study design</head><p xml:id="_bUxWRS3"><s xml:id="_QhuBSct">This study was a cross-sectional survey on RCTs involving traditional statistical or artificial intelligence (TS/AI) tool interventions in peer-reviewed clinical research journals.</s><s xml:id="_xUEqGqD">The inclusion criteria of RCTs were that (1) the study should be conducted with patients or health professionals, or both, in a clinical setting (population), (2) TS/AI prediction tools were used as a clinical intervention in RCTs (intervention), (3) any types of control group were selected (comparison), ( <ref type="formula">4</ref>) quantitative outcomes of the study were presented (outcome), and (5) the article was written in English.</s><s xml:id="_CCA6Kqq">The exclusion criteria included (1) studies that were not relevant to interventions using TS/AI tools, (2) reviews and/or meta-analysis, (3) studies of model development and/or validation, (4) observational studies, (5) study protocols or pilot studies, (6) editorial/letters/comments/case report, and (7) studies not in the field of interest.</s><s xml:id="_e4AM6hR">In the current review, we categorized trials into three groups according to the types of intervention tools in clinical practice.</s><s xml:id="_BMmASUH">They were trials involving interventions evaluating TS, ML, and DL tools, respectively.</s><s xml:id="_FBz9kdD">AI tools included ML and DL algorithms.</s><s xml:id="_w8QvTCV">Though deep learning is a subset of machine learning, the category of ML in the current study did not include DL algorithms.</s><s xml:id="_XD7GnUQ">TS models mainly used regression modeling methods, ML included machine learning algorithms, computer-aided diagnosis, Bayesian analysis, and DL used deep convolutional neural networks.</s><s xml:id="_dPCfHM6">No human subjects were involved because the study was mainly a survey of public data and no written informed consent was needed.</s><s xml:id="_WhQ7ud6">Studies for prediction tool development and validation of each randomized trial were investigated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wxsKRvu">Search strategy and data sources</head><p xml:id="_Wfjf3G9"><s xml:id="_rsx9KJd">We searched PubMed (to Oct 2020) for published papers within the title, abstract, and keywords of the articles.</s><s xml:id="_8w7Kks6">We divided search terms in PubMed into four groups: DL-related terms, ML-related terms, prediction tool-related terms, and terms relating to RCTs.</s><s xml:id="_BKKtkjD">Terms within groups and DL, ML, and prediction tool-related terms were combined with RCTs using the Boolean operator AND, respectively, and the resultant three subgroups were combined using the Boolean operator OR.</s><s xml:id="_VjHa9Nc">We referred and modified filters from previous studies <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b43">44</ref> to identify AI studies, prediction tools, and RCTs and provided search strategies in Supplementary Note 1.</s></p><p xml:id="_T2JmCne"><s xml:id="_2d3f8aA">A search was also conducted in the clinical trial registry website (clinicaltrials.gov, to Oct 2020) using the terms 'artificial intelligence', 'machine learning', 'deep learning' and 'prediction model/ tool' to identify finished clinical trials for TS/AI interventions.</s><s xml:id="_j9pDdsA">Furthermore, reference lists of each relevant impact analysis study were included to identify possible additional studies.</s><s xml:id="_zzsg6Cc">Y.h.C. and Q. Z. independently screened the identified articles following the literature search to minimize selection bias.</s><s xml:id="_V5CzeWb">Any disagreements were resolved by discussion till all investigators reached a consensus.</s></p><p xml:id="_pwdmP8R"><s xml:id="_d73Kd73">We screened the abstracts of the candidate articles for inclusion and subsequently read the full text of the articles deemed eligible according to the inclusion criteria.</s><s xml:id="_apjtJ5g">Subsequently, we excluded those ineligible articles and articles not providing sufficient information about the application of TS/AI tools.</s><s xml:id="_WJzXehv">The studies for prediction tool development and/or validation of each randomized trial were searched according to the descriptions and the citation of the references of the paper.</s><s xml:id="_XNZ6NzS">The systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines <ref type="bibr" target="#b44">45</ref> .</s><s xml:id="_wcfKybe">Supplementary Table <ref type="table" target="#tab_2">1</ref> shows a completed PRISMA checklist.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5uyQrtN">Data collection and definition</head><p xml:id="_srkASb7"><s xml:id="_YKCryzM">Data extraction was performed by Y.h.C. and Q.Z. using an Excel spreadsheet (Excel for Windows 2013; Microsoft, Redmond, WA, USA) with the following items for each relevant article: (1) first author; (2) year of publication; (3) type of TS/AI tools (TS, ML, or DL); (4) target of TS/AI tools (assistive diagnosis, risk stratification, assistive treatment decision, or others); (5) algorithms of TS/AI tools; (6) input and output; (7) controls; (8) clinical domain or condition; (9) application setting: inpatient, outpatient, home; (10) performance of the algorithm in model development and/or validation measured by the area under the receiver operating characteristic (AUC) and accuracy, and their 95% confidence intervals; (11) primary outcome of interest: whether it was significantly positive or not, and how the outcome was being used; (12) number of enrolled participants; (13) planned sample size (sufficient or not, defined as the number of enrolled participants larger or equal to the planned number); (14) duration of studies; (15) referenced CONSORT (yes or no); (16) study design and relevant features: masking (open-label, single-blinded or double-blinded), intent-to-treat (ITT) analysis (yes or no), and subgroup analysis (yes or no).</s><s xml:id="_d8rVGHX">For observational studies of model development and/or validation, we exacted data including year of publication, study type (prospective or retrospective), sample size for model development, whether the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis [TRIPOD] <ref type="bibr" target="#b45">46</ref> was referenced (yes or no), and performance of the algorithm in model development and/or validation measured by AUC and/or accuracy.</s></p><p xml:id="_ZM6mvZ5"><s xml:id="_Nq8SNeM">Because of the heterogeneity of these trials, the actual effect size for each trial was not able to be synthesized.</s><s xml:id="_FgbjeSb">According to the statistical significance of the primary outcome of interest, we classified a trial as positive if the proposed primary outcome of interest was reached, which means the null hypothesis was rejected, if the 95% confidence intervals excluded the null hypothesis or if the pre-specified target was met.</s><s xml:id="_TjePErC">If the primary objective was not stated, a trial was considered positive if the TS/ AI tool was superior to the specified control or standard treatment.</s><s xml:id="_M2VPuqg">In describing the TS/AI interventions, the number of predictors, the outcome the algorithm was predicting, and how the outcome was being used to make a decision in the trial were documented.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_s6pUm79">Methodological and reporting quality assessment</head><p xml:id="_wcSMzAV"><s xml:id="_u43TVqH">The quality of each article was independently performed by two reviewers (Q.Z. and Y.h.C.).</s><s xml:id="_FGr93Qh">RCTs were assessed according to the Cochrane Collaboration's tool for risk of bias <ref type="bibr" target="#b42">43</ref> .</s><s xml:id="_AwD9Pen">Checked risk of bias and data for published trials were presented.</s><s xml:id="_gKcg6h6">The quality of reporting was assessed according to whether the CONSORT statement was referenced or not <ref type="bibr" target="#b39">40</ref> .</s><s xml:id="_X2u5cEw">We did not use the CONSORT-AI extension as a reference because the included articles were published before the statement extension was released.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mBr89Ju">Statistical analysis</head><p xml:id="_Zg6JWW3"><s xml:id="_7DBjhF5">Continuous variables were presented as mean Â± standard deviation (SD) or median (interquartile range, IQR), as appropriate, and categorical variables as numbers and percentages.</s><s xml:id="_Rs7HND4">Comparisons between two groups were made using t test or Mann-Whitney U test for continuous variables and Fisher's exact test for categorical variables because of small sample size.</s><s xml:id="_wZHWHRw">Subgroup analysis was performed according to the risk of bias of trials.</s><s xml:id="_XyretZP">P value &lt; 0.05 was considered statistically significant.</s><s xml:id="_2pJWcYG">All statistical analyses and plots were performed using the R version 3.6.0</s><s xml:id="_zPDvdgv">software (Bell Laboratories, Murray Hill, NJ; <ref type="url" target="https://cran.r-project.org/bin/windows/base/old/3.6.0/">https://cran.r-project.org/bin/  windows/base/old/3.6.0/</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_97V94Ng">RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wS6Kmf6">General characteristics</head><p xml:id="_82QcUXW"><s xml:id="_3Sz2XaF">We screened 26,082 records through PubMed and the registry website from Jan 2010 to Oct 2020, and included 65 trials from 63 articles in the final review and analysis (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_CNJPzzx">There were two articles including two trials conducted in a different population or clinical settings.</s><s xml:id="_7WzXs6Y">As we mainly focused on the quality and effectiveness of the studies, we included all the trials separately in each article.</s><s xml:id="_mbdSZBm">A list of included RCTs is shown in Supplementary Table <ref type="table" target="#tab_3">2</ref>.</s></p><p xml:id="_dXyUnhd"><s xml:id="_Yb4ejUd">Of the 65 RCTs, 67.7% were published in 2016 or later.</s><s xml:id="_rUyWmvG">RCTs evaluating DL interventions emerged in 2019.</s><s xml:id="_famverB">The number of published trials increased over time, with 11 (16.9%), 17 (26.2%),</s><s xml:id="_3hw42R4">and 37 (56.9%)</s><s xml:id="_5rhEdwz">trials involving DL, ML, and TS prediction tools, respectively (Fig. <ref type="figure" target="#fig_1">2a</ref>).</s><s xml:id="_jCj5wkt">Most RCTs did an open-label (75.4%) randomized controlled superiority design (73.8%) with 1:1 allocation ratio (84.6%), and recruited at a single center (50.8%) over a median duration of 12 months for a median sample size of 435 (IQR: 192, 999).</s><s xml:id="_WupXRE6">The function of these tools in clinical practice included assistive treatment decision (53.8%), assistive diagnosis (24.6%), risk stratification (18.5%), and others (3.1%).</s><s xml:id="_D3Sywuk">The top three covered conditions were acute disease (29.2%), chronic disease not including cancer (27.7%), and cancer (16.9%) (Table <ref type="table" target="#tab_2">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_S4dnhnH">Quality of reporting and risk of bias assessment for trials involving interventions evaluating traditional statistical and artificial intelligence prediction models</head><p xml:id="_Yb9cacX"><s xml:id="_BUGvAV8">The distributions of risk of bias by each domain and the overall risk of bias of all trials and by types of tools are depicted in Fig. <ref type="figure" target="#fig_2">3a</ref>, <ref type="figure">b</ref>.</s></p><p xml:id="_jPkBGvF"><s xml:id="_dsCJZ8M">Blinding of participants and personnel, other bias, blinding of outcome assessment showed a more frequent high risk of bias than other domains.</s><s xml:id="_GD2rps3">Seventeen trials (26.2%) were considered to have an overall low risk of bias, 38.5% some concerns, and 35.4% overall high risk.</s><s xml:id="_rGYgyWB">When stratified by types of tools, more (46%) trials evaluating DL tools showed a low risk of bias and less (18%) showed a high risk of bias, and nearly half of the trials (43%) involving TS as interventions showed an overall high risk of bias, but the difference was not statistically significant among the three groups (P = 0.395).</s><s xml:id="_KvJNGDC">Nearly three quarters (72.3%) did not reference the CONSORT statement in reporting of the trials.</s><s xml:id="_ysBGMJb">Nineteen RCTs (32.3%) did not perform sample size pre-estimation and seven trials (10.8%) recruited subjects less than expected.</s><s xml:id="_myBF6Ej">Most (60.3%) of the trials did not use or mention intent-to-treat analysis.</s><s xml:id="_XNdyBZZ">All trials were registered in advance, but study protocols were not available in most of the trials (75.4%) (Table <ref type="table" target="#tab_2">1</ref>).</s></p><p xml:id="_Dx7Keg9"><s xml:id="_XfHUNfg">26082 Research identified through Pubmed MEDLINE databases searching 65 Randomized controlled trials from 63 articles finally included in analysis with 58 relevant observational validation studies 25024 Records excluded 809 Review articles 382 Study Protocols 2913 Model development 7460 Irrelevant intervention 9346 Observational studies 23 Editorial/ Letters/ Comments/ Case report 4091 Not in field of interest 43 Records excluded 3 Review articles 21 Irrelevant intervention 9 Model development 5 Secondary analysis using randomized trial data 5 Observational studies 963 Duplicate records excluded 25119 Records screened 95 Full-text articles for eligibility 25119 Records after duplicate removed n o i t a c i f i t n e d I g n i n e e r c S y t i l i b i g i l E d e d u l c n I Other sources -4 from Clinical trial registry -7 Reference lists AI tool intervention and its performance in both observational model development and/or validation study and randomized controlled trial All studies reported the P value from a comparison of the primary outcome of intervention and control groups.</s><s xml:id="_uwQP8aK">Compared with the control group, two-fifths (38.5%) of the trials showed no benefit as no statistically significant difference for the primary outcome while 61.5% showed positive results (Table <ref type="table" target="#tab_2">1</ref>).</s><s xml:id="_Suc3qXU">The number of trials with positive results for primary outcome increased with time, but the number of trials with negative results did not change much (Fig. <ref type="figure" target="#fig_1">2b</ref>).</s><s xml:id="_RWCByQk">We found that 58 trials (89%) had model development studies.</s><s xml:id="_Zpeb6hw">Nine of them were published in the same paper with the RCT, and 49 were published independently before the trial.</s><s xml:id="_AChJMsz">Model development studies were not found in seven trials (10.8%), five from TS and two from ML.</s><s xml:id="_gGyMzJp">Most (64.6%; 42/65) of the trials had internal validation using methods of cross-validation, bootstrapping, random split, and split-sample by time point, and 61.5% (40/ 65) had external validation which was defined as making validation in independent datasets before the corresponding RCT was conducted.</s><s xml:id="_HJxKQ6m">These observational studies had a median sample size of 1392 (IQR: 192, 10,356).</s><s xml:id="_A3fSZ3h">Most (63.1%) of them were retrospective studies and some (16.9%) were prospective.</s><s xml:id="_pz4J6PP">Only two studies were reported according to the TRIPOD guidance which has been widely used for reporting clinical prediction models.</s><s xml:id="_ppxytMt">In terms of model performance, 21 of them reported a median AUC of 0.81 (IQR: 0.75, 0.90) in model development.</s><s xml:id="_SEQVnfT">The median AUCs were 0.78 (IQR: 0.73, 0.88; n = 18), 0.83 (IQR: 0.79, 0.97; n = 11) in internal and external validation, respectively.</s><s xml:id="_hDQhfnJ">Data of AUC were not available mainly because of different methods for assessing model performance or not being reported in the final paper.</s><s xml:id="_q52Ggbp">More information on observational studies is shown in Supplementary Table <ref type="table" target="#tab_5">3</ref>.</s></p><p xml:id="_ZPJjYsV"><s xml:id="_h5wEhrt">Table <ref type="table" target="#tab_3">2</ref> and Supplementary Table <ref type="table">4</ref> show the brief descriptions of 28 RCTs involving deep learning and machine learning interventions in terms of conditions, sample size, tools for intervention and control group, algorithms, the input and output of the tool, how the output is being used in clinical settings, trial outcomes, the gold standard of the outcome, trial findings.</s><s xml:id="_WH76S9c">Most DL tools were developed for the diagnosis of gastroenterological oncology, but they showed slight differences in the tool outputs.</s><s xml:id="_Q3QxXQz">The control group in these trials was routine clinical examination, such as colonoscopies, esophagogastroduodenoscopy.</s><s xml:id="_B69AgJk">In order to avoid potential operational bias, one DL trial used a sham AI system as control, so that a double-masked design could be performed.</s><s xml:id="_8gskYy9">Most ML tools exhibited assistive function of patient management and treatment decision for chronic disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KzyeAGc">Comparisons among trials involving interventions of traditional statistical, machine learning, and deep learning tools</head><p xml:id="_et3w9cg"><s xml:id="_TysqGgA">The intervention tools were classified into three categories according to their types of algorithms (Table <ref type="table" target="#tab_5">3</ref>).</s><s xml:id="_dDNWgMP">implemented in different clinical settings (P = 0.015).</s><s xml:id="_sA4wcMP">A majority of DL interventions were for inpatients and used non-quantitative clinical data such as computed tomography (CT), magnetic resonance imaging (MRI), slit-lamp photography, colonoscopy, or esophagogastroduodenoscopy.</s><s xml:id="_wYVQyE8">The proportions of disease categories and the function of prediction models were not consistent among the three types of interventions (both P &lt; 0.001).</s><s xml:id="_qk7t6M2">Trials evaluating DL interventions were more likely conducted in cancer research, such as colorectal cancer, upper gastrointestinal cancer, and all of them were for the purpose of disease assistive diagnosis.</s><s xml:id="_YsYjcV3">ML interventions were more frequently used in chronic diseases, not including cancer such as obesity, work disability, anemia, and so on, and a majority of them were used for assistive treatment decisions and some for assistive diagnosis.</s><s xml:id="_BmcrJV8">While TS tool interventions were more in acute diseases such as mechanical acute small bowel obstruction, acute heart failure, treatment decisions in intensive care units, and their purposes were diverse including assistive treatment decision, risk stratification, and assistive diagnosis.</s></p><p xml:id="_RN9by8H"><s xml:id="_Zsh9bDy">The positive rates of primary analysis were different among trials involving interventions evaluating TS, ML, and DL tools (51.4%, 70.6%, 81.8%, respectively; P for Fisher exact test = 0.136, P for trend = 0.044) (Fig. <ref type="figure" target="#fig_1">2c</ref>, <ref type="figure">d</ref>).</s><s xml:id="_PNcSzsY">However, when we stratified by the risk of bias (low, some concerns, high), the distribution of the positive rate of results was changed (Fig. <ref type="figure" target="#fig_3">4</ref>).</s><s xml:id="_uYDswU7">In trials with low risk of bias, the positive rate of trials involving TS tools increased to 63%, ML tools decreased to 25%, and DL tools remained (80%), but no statistically significant difference was found (P for Fisher exact test = 0.374, P for trend = 0.660; Fig. <ref type="figure" target="#fig_3">4a</ref>, <ref type="figure">b</ref>).</s><s xml:id="_r4ZbTVK">Only in the subgroup of high risk of bias, the positive rates were significantly different (TS, ML, DL: 44%, 100%, 100%, P for Fisher exact test = 0.035, P for trend = 0.019; Fig. <ref type="figure" target="#fig_3">4e</ref>, <ref type="figure">f</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vaWhW6C">DISCUSSION</head><p xml:id="_a2Bsyst"><s xml:id="_ykQJBhk">In the current study, we found that the number of RCTs evaluating TS/AI interventions increased with year in the past decade, and trials involving AI tools multiplied in recent 2 years.</s><s xml:id="_4nDHWPP">However, we should be cautious about the clinical application of TS/AI prediction tools before the effectiveness has been proved in rigorous clinical research.</s><s xml:id="_cGNRv9f">This review showed that only a quarter of trials were assessed to be low risk of bias.</s><s xml:id="_H9fpCzm">Consistent with other studies reviewing the quality of RCTs in both general medical fields and in AI <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b46">47,</ref><ref type="bibr" target="#b47">48</ref> , the quality of the trials in the current study tended to be suboptimal in the aspects of referenced CONSORT statement, sample size pre-estimation, randomization, masking, and intent-to-treat analysis.</s><s xml:id="_hsAApSp">In addition, in this crosssectional survey through published literature of 65 RCTs, two-fifths of TS/AI prediction tools that achieved good performance in observational model development and/or validation studies failed to show clinical benefit for patients compared to routine clinical treatment.</s><s xml:id="_XfgFzS5">DL and ML tools exhibited superiority to TS tools with regard to the percentage of positive results.</s><s xml:id="_yvMwYdp">However, in trials with a low risk of bias, this advantage in DL remained but disappeared in ML.</s><s xml:id="_4pGhFvH">The percentage of positive rate remained in DL trials, and increased in TS trials, but decreased a lot in ML trials.</s></p><p xml:id="_F4Sb5jv"><s xml:id="_G9hjGE2">We focused on RCTs involving interventions evaluating TS/AI prediction tools to make the assessment and evaluation of the effectiveness of the TS/AI-based interventions as well as the quality of these studies.</s><s xml:id="_wY9bSmM">In recent 2 years, a few studies have been published to review the current situation of AI-based interventional studies from RCTs to evaluate its effectiveness, quality, and methodology <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> .</s><s xml:id="_DQPX2gy">They were reviews including five, eight, and two AI-based RCTs, respectively.</s><s xml:id="_xfDzWrH">Cresswell et al. <ref type="bibr" target="#b37">38</ref> selected AIbased RCTs because they thought that, compared with other observational research designs, the risk of bias of RCTs was the lowest.</s><s xml:id="_7qjTktu">Triantafyllidis et al. <ref type="bibr" target="#b38">39</ref> found that digital health intervention involving AI could be useful and effective based on eight RCTs.</s><s xml:id="_PemWtMN">But IQR interquartile range, AUC area under the receiver operating characteristic curve.</s></p><p xml:id="_VSYX6Ze"><s xml:id="_pmB6u3Q">a Available numbers used for description five of them were pilot studies or studies of wearable devices, which were inconsistent with the inclusion criteria of the current study.</s><s xml:id="_VrVtjWB">In short, although a small number of previous studies have discussed the situation of AI-based interventional studies in several medical fields, these reviews were unable to make quantitative analysis and conclusions because of their small sample size and less rigorous methodology.</s><s xml:id="_xPpkEuj">Therefore, we made broader criteria for including RCTs to evaluate the clinical effectiveness of AI prediction tools and compared them with TS trials.</s><s xml:id="_JZFdkZt">In the present study, we focused on prospective RCTs not only in medical images but also in other medical fields.</s><s xml:id="_rvTUr3z">Although there are inherent limitations in RCTs <ref type="bibr" target="#b48">49</ref> , we believe that as a gold standard design, the results from RCTs could help us to understand more about the progress and effectiveness of TS/AI tool interventions.</s></p><p xml:id="_Tg9kcPg"><s xml:id="_2Hh448T">A total of 65 RCTs were included in the current study, and nearly half of them used AI tools as interventions.</s><s xml:id="_ztbfEkW">We found a moderate proportion of negative results in these trials.</s><s xml:id="_s34cz4Z">This indicated that even achieving good performance in model development and being well-validated, prediction-tool-based interventions might fail to show clinical benefit for patients when compared to routine care in RCTs.</s><s xml:id="_G3DSvkm">No agreement has been reached on how much evidence is needed before a prediction tool could be utilized in clinical work.</s><s xml:id="_wM6zqW2">Some researchers 9 tried to adopt clinical trial phases for the drug development process to simulate the development process of medical image mining tools.</s><s xml:id="_A4VpM7B">According to their proposed process, a prospective design for validation with more than 100 sample sizes was defined as Phase III.</s><s xml:id="_AQrXpFG">However, the identified eight "Phase III trials" in their study were less evidence to be implemented in clinical settings <ref type="bibr" target="#b49">50</ref> .</s><s xml:id="_PbTUCwK">Nagendran et al. <ref type="bibr" target="#b10">11</ref> reviewed 83 published clinical studies of deep learning in medical imaging diagnosis from 2010 to June 2019 and found that the superiority of AI tools over clinicians was overpromising.</s><s xml:id="_EPdnj7c">But there were only nine prospective deep learning studies and two randomized trials existing in medical imaging, so their conclusions were largely based on retrospective studies.</s><s xml:id="_52kYjPp">Our study included more AI RCTs than previous reviews and we chose TS trials as comparisons.</s><s xml:id="_ym37hwh">Through the results of these RCTs, we found that although AI tools showed more percentages of better clinical outcomes than traditional care or routine examination than that of TS tools, in the subgroup of low-risk of bias studies, the rate of a positive result in TS trials increased a lot and was not inferior to that of AI tools.</s><s xml:id="_V3ZduUv">Therefore, we believe that high-quality clinical trial designs, such as RCTs, are still required to assess the effectiveness of TS/AI prediction tools before they are implemented in clinical settings.</s><s xml:id="_GHw3YwK">CONSORT-AI group <ref type="bibr" target="#b40">41</ref> has been working on the reporting guideline for clinical trials evaluating AI interventions, which will help evaluate the reporting of these trials.</s></p><p xml:id="_cC4sJtN"><s xml:id="_wqgxZQJ">In addition, a high-quality and rigorous study design was required to conduct RCTs evaluating TS/AI interventions.</s><s xml:id="_EyHas7W">In our study, the quality of the included trials was variable, which is consistent with several previous reviews <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref> .</s><s xml:id="_w5XgpGB">Principles of trials' design such as masking, randomization, and allocation concealment, reporting referenced CONSORT statement was not well  Table 2 continued Reference Conditions Sample size Tools for intervention Control Algorithms Tool Tool input Tool output How the output being used in clinical settings Trial primary outcomes Gold standard Trial findings Colorectal cancer 157 AI-assisted colonoscopy Traditional colonoscopy CNN (YOLO) Assistive diagnosis Colonoscopy images Location of polyps Endoscopists referenced AI output to make endoscopic examination and report of polyps.</s><s xml:id="_wqWWnq5">Polyp detection rate Not reported Positive Repici (2020) 62 Colorectal cancer 685 High-definition colonoscopies with the AI-based CADe system Routine colonoscopy CNN Assistive diagnosis Colonoscopy images Location of polys Endoscopists referenced AI output to make endoscopic examination and report of polyps and adenomas.</s><s xml:id="_G9NjdMG">Adenoma detection rate Pathology Positive Wang (2020) 61 Colorectal cancer 962 White light colonoscopy with assistance from the CADe system White light colonoscopy with assistance from a sham system Deep learning architecture Assistive diagnosis Colonoscopy images Location of polyps; alarming Endoscopists were required to check every polyp location detected by the system and report of polyps and adenomas.</s><s xml:id="_Dth5d6k">Adenoma detection rate Pathology Positive Blomberg (2021) 58 Out-of-hospital cardiac arrest (OHCA) 5242 Normal protocols with alert Normal protocols without alert Speech recognition using deep neural networks Assistive diagnosis Emergency calls OHCA Alert Dispatchers in the intervention group were alerted when the machine learning model identified out-of-hospital cardiac arrest.</s><s xml:id="_AsWgH9V">The rate of dispatcher recognition of subsequently confirmed OHCA Danish Cardiac Arrest Registry Negative AI artificial intelligence, DL tools using deep learning algorithms, ML tools using machine learning algorithms, CNN convolutional neural networks, DCNN deep convolutional neural networks, CADe computeraided detection, EGD esophagogastroduodenoscopy, OHCA out-of-hospital cardiac arrest.</s></p><p xml:id="_QYRBsQk"><s xml:id="_FKjDHWp">followed in the included trials.</s><s xml:id="_GmpfCC2">It is worth noting these issues are not unique to TS/AI trials.</s><s xml:id="_RGcMmWY">In fact, in previous RCTs in general, the quality was found to be well below an acceptable level <ref type="bibr" target="#b46">47,</ref><ref type="bibr" target="#b47">48</ref> .</s><s xml:id="_qNdTaTG">In addition, the risk of bias assessment showed a low proportion of low risk and a high proportion of high risk of bias in the included trials.</s><s xml:id="_zwbQbsH">In doing the assessment, we focused on randomization and masking.</s><s xml:id="_M2VGvET">Some of the trials <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref> gave the reason why they did not use masking for its difficulty or its nature of the intervention, and some would be not influenced by non-masking <ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref> .</s><s xml:id="_aar7PwM">Masking was also related to study design (i.e.</s><s xml:id="_QqVMQ87">stepped-wedge cluster RCTs) <ref type="bibr" target="#b56">57</ref> .</s><s xml:id="_SYFB6JA">Therefore, we did not consider such open-label trials as high risk in the blinding domain of risk of bias assessment after a comprehensive evaluation.</s><s xml:id="_fKKFMGR">Encouragingly, four trials used double-blinded design <ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref><ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref> .</s><s xml:id="_bPME3sp">One of them is a DL trial <ref type="bibr" target="#b60">61</ref> to assess the effectiveness of an AI system compared with a sham system so that participants could be blinded to study groups.</s><s xml:id="_4CqGjat">A sham system was adopted as a control, which was developed from polyp-like non-polyp structure with high sensitivity and zero specificity to detect polyps.</s><s xml:id="_mZvtzcF">This allowed avoiding potential operational bias.</s></p><p xml:id="_VFexSaG"><s xml:id="_sPngr6A">Although cluster randomization was recommended to a preferred design by researchers more than 10 years ago <ref type="bibr" target="#b26">27</ref> , there was a fifth of trials using clustered randomization.</s><s xml:id="_Wt5BhRd">In order to compare with human performance or routine clinical treatment, most trial hypotheses were that the prediction tool would show superiority to clinicians.</s><s xml:id="_BfmDjbT">Non-inferiority design (2/65) would be a choice to prove that the performance of the prediction tool is not inferior to expertise <ref type="bibr" target="#b61">62</ref> .</s><s xml:id="_8QcgymQ">This study showed that DL tools tended to obtain more positive results compared to ML and TS models.</s><s xml:id="_YhrRBGU">However, RCTs involving DL tools nowadays were conducted in a narrower field of diseases and had simpler targets than that of ML and TS trials.</s><s xml:id="_4BPYkys">For example, DL prediction tools were mostly for the diagnosis and detection of colorectal cancer.</s><s xml:id="_43uGBd8">Of note, there were seven trials concerning AI's application in colonoscopy.</s><s xml:id="_PY9UzBZ">This is relevant to the increasing number of published studies on the AI model construction of colonoscopy in recent years <ref type="bibr" target="#b7">8</ref> .</s><s xml:id="_Rkn8JtC">Consistent with other reviews in deep convolutional neural network-based AI on colonoscopy <ref type="bibr" target="#b62">63</ref> , AI assistive colonoscopy was promising but still need more application in different population.</s><s xml:id="_xDY5aM3">ML and TS RCTs were conducted in more application scenarios for different purposes, showing great flexibility and uncertainty in results.</s><s xml:id="_eKHZZSP">For example, Bailey et al. <ref type="bibr" target="#b63">64</ref> in 2013 used a logistic regression prediction model to make realtime automated alerts for patients every day and send alerts to nurses to signify the risk of transfer to intensive care.</s><s xml:id="_5VgfRM3">Geersing et al. <ref type="bibr" target="#b53">54</ref> in 2020 used a Cox regression prediction model to estimate patients' recurrence risk and then make model-assisted treatment recommendations for patients.</s><s xml:id="_yqYcaSg">These RCTs tried to solve important clinical problems but unfortunately failed.</s><s xml:id="_tv4h3Fd">Of note, the percentage of a positive rate of TS trials increased from 51% in all the trials to 63% in the low-risk trials, while ML interventions decreased from 71% in all the trials to 25%.</s><s xml:id="_vgPJA3J">This change after stratifying by the risk of bias was also observed in observational studies for prediction model development which showed that no performance benefit of ML over logistic regression for clinical prediction models <ref type="bibr" target="#b21">22</ref> .</s><s xml:id="_ybJerNy">The current applications of AI are not yet fully spread performed in medicine, and in the future, it will integrate more clinical problems like ML and TS tools.</s><s xml:id="_UDZphk3">This gives us a hint that if AI tools will be used in a wider range of scenarios in medicine in the future, the process may be more complex and results may face more uncertainty.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pEZHuRj">Limitations</head><p xml:id="_BZudXSm"><s xml:id="_STzTzyV">There were some limitations in the study.</s><s xml:id="_Ye9276c">Firstly, although comprehensive, our search might have missed some studies that could have been included.</s><s xml:id="_Qq3psDu">In order to validate our search strategy, we specifically paid close attention to trials in high-quality journals and also searched for specific studies or study designs, such as TS randomized controlled trials involving traditional statistical tool as intervention, ML randomized controlled trials involving tool using machine learning algorithms not including deep learning as intervention, DL randomized controlled trials involving tool using deep learning algorithm as intervention.</s></p><p xml:id="_ygSg8Ec"><s xml:id="_uEWuVnf">trials for computer decision support, TS/AI trials using a cluster randomized design, and reports of relevant trials on websites.</s><s xml:id="_mAUq8ZR">Second, given the heterogeneity of these published trials, no meta-analysis was performed.</s><s xml:id="_UzfS7qe">The current study was a systematic review of trials involving interventions evaluating TS/AI prediction tools, and we analyzed the quality of methodology and risk of bias of the included trials.</s><s xml:id="_Awfyxpc">Third, the trials included in this review were published before the publication of CONSORT-AI extension <ref type="bibr" target="#b41">42</ref> , so we did not evaluate the reporting of these trials according to the new guidance.</s><s xml:id="_Qqqcusu">We extracted information on whether these trials referenced CONSORT <ref type="bibr" target="#b39">40</ref> or not.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sBcnJjM">Future work</head><p xml:id="_vE6bt2K"><s xml:id="_rrPyVXc">Based on our study, we made some recommendations for future research.</s></p><p xml:id="_y7GNbqj"><s xml:id="_udXjgME">Rigorous trial design such as randomized controlled trial to study evaluating TS/AI tools.</s><s xml:id="_JxXd4r2">This could make the evidence of the performance of a TS/AI tool more reliable before it is used in clinical practice and accelerate clinical translation.</s></p><p xml:id="_DmdQSTj"><s xml:id="_Quw8TxU">Application of CONSORT-AI for reporting.</s><s xml:id="_WgQWjhD">The articles reporting RCTs evaluating TS/AI tools should comply with CONSORT-AI <ref type="bibr" target="#b41">42</ref> before publication.</s><s xml:id="_GjS3fKs">This could improve the quality of reporting of RCTs evaluating TS/AI tools.</s></p><p xml:id="_cQ2gHBK"><s xml:id="_eZBAPb4">Development of specific tools of evaluating the risk of bias for RCTs evaluating TS/AI tools.</s><s xml:id="_jAUfaa8">Currently, there is no specific standard for the assessment of the risk of bias for RCTs evaluating TS/AI tools.</s></p><p xml:id="_6rgfMvA"><s xml:id="_yGhuQVS">With the rapid development of AI tools, it is urgent to develop a specific tool for evaluating the risk of bias of these studies, which can make the results and conclusions of this kind of trials more convincing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6wRa9bt">CONCLUSION</head><p xml:id="_Pae5dB9"><s xml:id="_w4JyXtZ">Although negative results have been consistently reported in RCTs involving TS/AI prediction tools, an increasing proportion of studies with positive results in DL prediction tool interventions showed promising perspectives.</s><s xml:id="_EzDNVcJ">Whereas the current applications of DL tools are not yet fully widely performed in medicine, and in the future, it will integrate more clinical problems like ML and TS tools.</s><s xml:id="_wSwfds6">However, ML tools in RCTs showed variable results because in trials at low risk of bias, ML tools got a very low rate of positive results compared to the other two kinds of tools, while in trials with a high risk of bias, it performed much better.</s><s xml:id="_VZ3JcDk">Therefore, we believe that rigorous trial is necessary to obtain evidence of prediction tool interventions.</s><s xml:id="_SU9R4gZ">The experience of RCTs involving ML and TS tools indicates that we should be cautious about the effectiveness of DL when applied to more complex clinical problems and long-term interventions.</s><s xml:id="_7wBxCsh">In addition, high-quality RCTs with transparent reporting are needed to evaluate the efficacy of intelligence prediction models in clinical settings.</s><s xml:id="_VVcYvct">Prediction tools with DL algorithms for clinical decision-making are the future trend and will be used in the treatment needs of millions of people.</s><s xml:id="_gr38cG4">Using high-quality research to carefully validate the most clinically valuable tools for clinical practice will help reduce the burden on physicians and protect subjects.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p xml:id="_HbSuevK"><s xml:id="_7yUfzFg">Fig.1Flowchart of the study.</s><s xml:id="_uEp4b6y">Published trials were searched on PubMed.</s><s xml:id="_y4zWngg">Clinical trial registry and references in the full-text articles for eligibility were also checked to include potentially relevant trials.</s><s xml:id="_fJtuKn8">Clinical trial registry was the clinicaltrial.gov</s><s xml:id="_wDYGZSm">registry website.</s><s xml:id="_eKZdyru">The observational studies for tool development and/or validation were searched according to the descriptions and the references of the clinical trial paper.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2</head><label>2</label><figDesc><div><p xml:id="_VZJgfCF"><s xml:id="_kNGWfZe">Fig. 2 Distribution of the number of trials and percentage of trials with positive results.</s><s xml:id="_Vg8FpVR">a The trend of published randomized controlled trials involving traditional statistical and artificial intelligence prediction tool interventions with years; b the trend of the number of trials with positive and negative results; c number of trials with positive results by three types of prediction tools; d percentage of trials with positive results by three types of prediction tools.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3</head><label>3</label><figDesc><div><p xml:id="_fmrW9u6"><s xml:id="_UMNfzxN">Fig. 3 Risk of bias assessment.</s><s xml:id="_wtMMvtw">a The distributions of risk of bias by each domain; b the distributions of the overall risk of bias for all trials and for traditional statistical, machine learning, and deep learning tools, respectively.</s></p></div></figDesc><graphic coords="6,140.09,59.30,324.74,367.43" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4</head><label>4</label><figDesc><div><p xml:id="_TkpDNpc"><s xml:id="_CHYJdwn">Fig.4The number of trials and percentage of positive results of three types of tools according to the risk of bias.</s><s xml:id="_xWmj53w">a The number of trials of each type of tool in trials with low risk of bias; b the percentage of positive results of each type of tool in trials with low risk of bias; c the number of trials of each type of tool in trials with some concerns; d the percentage of positive results of each type of tool in trials with some concerns; e the number of trials of each type of tool in trials with a high risk of bias; f the percentage of positive results of each type of tool in trials with a high risk of bias.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_qFduUFA"><s xml:id="_K4uNdM6">General characteristics of the 65 randomized controlled trials.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>Levels</cell><cell>Total (n = 65)</cell></row><row><cell>Results (%)</cell><cell>Negative</cell><cell>25 (38.5)</cell></row><row><cell></cell><cell>Positive</cell><cell>40 (61.5)</cell></row><row><cell cols="2">Duration of study (n a = 59, months, median [IQR])</cell><cell>12 [6, 24]</cell></row><row><cell>Sample size (median [IQR])</cell><cell></cell><cell>435</cell></row><row><cell></cell><cell></cell><cell>[192, 999]</cell></row><row><cell cols="3">Sample size estimation (%) Larger or equal than expected 37 (56.9)</cell></row><row><cell></cell><cell>Less than expected</cell><cell>7 (10.8)</cell></row><row><cell></cell><cell>Not performed</cell><cell>21 (32.3)</cell></row><row><cell>Publication year (%)</cell><cell>2010-2015</cell><cell>21 (32.3)</cell></row><row><cell></cell><cell>2016-2020</cell><cell>44 (67.7)</cell></row><row><cell>Study design (%)</cell><cell cols="2">RCT superiority (individualized) 48 (73.8)</cell></row><row><cell></cell><cell>RCT superiority with crossover</cell><cell>1 (1.5)</cell></row><row><cell></cell><cell>(individualized)</cell><cell></cell></row><row><cell></cell><cell>RCT non-inferiority</cell><cell>2 (3.1)</cell></row><row><cell></cell><cell>(individualized)</cell><cell></cell></row><row><cell></cell><cell>Clustered RCT superiority</cell><cell>7 (10.8)</cell></row><row><cell></cell><cell>(clustered)</cell><cell></cell></row><row><cell></cell><cell>Stepped-wedge design</cell><cell>7 (10.8)</cell></row><row><cell></cell><cell>(clustered)</cell><cell></cell></row><row><cell>Allocation ratio (%)</cell><cell>1:1 parallel</cell><cell>55 (84.6)</cell></row><row><cell></cell><cell>Others</cell><cell>10 (15.4)</cell></row><row><cell>Masking (%)</cell><cell>Open-label</cell><cell>49 (75.4)</cell></row><row><cell></cell><cell>Single-blinded</cell><cell>12 (18.5)</cell></row><row><cell></cell><cell>Double-blinded</cell><cell>4 (6.2)</cell></row><row><cell>Centers (%)</cell><cell>Single</cell><cell>33 (50.8)</cell></row><row><cell></cell><cell>Multi</cell><cell>32 (49.2)</cell></row><row><cell>Disease category (%)</cell><cell>Cancer</cell><cell>11 (16.9)</cell></row><row><cell></cell><cell>Chronic disease not</cell><cell>18 (27.7)</cell></row><row><cell></cell><cell>included cancer</cell><cell></cell></row><row><cell></cell><cell>Acute disease</cell><cell>19 (29.2)</cell></row><row><cell></cell><cell>Primary care</cell><cell>9 (13.8)</cell></row><row><cell></cell><cell>Others</cell><cell>8 (12.3)</cell></row><row><cell>Types of algorithms (%)</cell><cell>Traditional statistical model</cell><cell>37 (56.9)</cell></row><row><cell></cell><cell>Machine learning</cell><cell>17 (26.2)</cell></row><row><cell></cell><cell>Deep learning</cell><cell>11 (16.9)</cell></row><row><cell>Prediction tools</cell><cell>Assistive treatment decision</cell><cell>35 (53.8)</cell></row><row><cell>function (%)</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Assistive diagnosis</cell><cell>16 (24.6)</cell></row><row><cell></cell><cell>Risk stratification</cell><cell>12 (18.5)</cell></row><row><cell></cell><cell>Others</cell><cell>2 (3.1)</cell></row><row><cell>Referenced CONSORT (%)</cell><cell>No</cell><cell>47 (72.3)</cell></row><row><cell></cell><cell>Yes</cell><cell>18 (27.7)</cell></row><row><cell cols="2">Intent-to-treat analysis (%) No</cell><cell>39 (60.0)</cell></row><row><cell></cell><cell>Yes</cell><cell>26 (40.0)</cell></row><row><cell>Study protocol available</cell><cell>No</cell><cell>49 (75.4)</cell></row><row><cell></cell><cell>Yes</cell><cell>16 (24.6)</cell></row><row><cell>Model development (%)</cell><cell>No</cell><cell>7 (10.8)</cell></row><row><cell></cell><cell cols="2">Yes-independent publication 49 (75.4)</cell></row><row><cell></cell><cell>Yes-published in the same</cell><cell>9 (13.8)</cell></row><row><cell></cell><cell>article with RCT</cell><cell></cell></row><row><cell>Internal validation (%)</cell><cell>No</cell><cell>23 (35.4)</cell></row><row><cell></cell><cell>Yes</cell><cell>42 (64.6)</cell></row><row><cell>External validation (%)</cell><cell>No</cell><cell>25 (38.5)</cell></row><row><cell></cell><cell>Yes</cell><cell>40 (61.5)</cell></row><row><cell cols="2">AUC in model development (n a = 21, median [IQR])</cell><cell>0.81</cell></row><row><cell></cell><cell></cell><cell>[0.75, 0.90]</cell></row><row><cell cols="2">AUC in internal validation (n a = 18, median [IQR])</cell><cell>0.78</cell></row><row><cell></cell><cell></cell><cell>[0.73, 0.78]</cell></row><row><cell cols="2">AUC in external validation (n a = 20, median [IQR])</cell><cell>0.83</cell></row><row><cell></cell><cell></cell><cell>[0.79, 0.97]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_3tavu9v"><s xml:id="_9PpxFCd">Procedures of predictive tool interventions the 11 randomized controlled trials involving interventions evaluating deep learning tools.</s></p></div></figDesc><table><row><cell>Trial findings</cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Negative</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Gold</cell><cell>standard</cell><cell></cell><cell>Experts</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Experts</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pathology</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pathology</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Experts</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pathology</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pathology</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Trial primary</cell><cell>outcomes</cell><cell></cell><cell>Mean blind</cell><cell>spot rate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Accuracy of</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adenoma</cell><cell>detection rate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adenoma</cell><cell>detection rate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Mean blind</cell><cell>spot rate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Adenoma</cell><cell>detection rate</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Detection rate of</cell><cell>polyps and</cell><cell>adenomas</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>How the output</cell><cell>being used in</cell><cell>clinical settings</cell><cell>Experts referenced</cell><cell>AI output to make</cell><cell>EGD examination</cell><cell>and monitor</cell><cell>blind spots.</cell><cell></cell><cell></cell><cell>AI made diagnosis</cell><cell>independently,</cell><cell>and its results</cell><cell>would be</cell><cell>comparted with</cell><cell>experts and not</cell><cell>impact clinical</cell><cell>decision making.</cell><cell>Endoscopists</cell><cell>referenced AI</cell><cell>output to make</cell><cell>endoscopic</cell><cell>examination and</cell><cell>report of polyps</cell><cell>and adenomas.</cell><cell>Endoscopists were</cell><cell>required to check</cell><cell>every polyp</cell><cell>location detected</cell><cell>by the system and</cell><cell>report of polyps</cell><cell>and adenomas.</cell><cell>Experts referenced</cell><cell>AI output to make</cell><cell>EGD examination</cell><cell>and monitor</cell><cell>blind spots.</cell><cell></cell><cell></cell><cell>Operating</cell><cell>endoscopists</cell><cell>referenced AI</cell><cell>output to make</cell><cell>endoscopic</cell><cell>examination and</cell><cell>report of polyps</cell><cell>and adenomas.</cell><cell>Endoscopists</cell><cell>focused mainly on</cell><cell>the main monitor</cell><cell>during the</cell><cell>examination</cell><cell>process, and a</cell><cell>voice alarm</cell><cell>prompted them to</cell><cell>view the system</cell><cell>monitor to check</cell><cell>the location of</cell><cell>each polyp</cell><cell>detected by the</cell><cell>system.</cell></row><row><cell>Tool input Tool output</cell><cell></cell><cell></cell><cell>EGD images A virtual stomach</cell><cell>model monitoring</cell><cell>blind spots; timing;</cell><cell>scoring and</cell><cell>grading</cell><cell></cell><cell></cell><cell>Ocular images from Diagnosis</cell><cell>slit-lamp outcome;</cell><cell>photography comprehensive</cell><cell>evaluation;</cell><cell>treatment</cell><cell>recommendation</cell><cell></cell><cell></cell><cell>Colonoscopy images Location of</cell><cell>colorectal polyps;</cell><cell>timing; reminding</cell><cell>retest and clean</cell><cell></cell><cell></cell><cell></cell><cell>Colonoscopy images Location of polyps;</cell><cell>alarming</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>EGD images A virtual stomach</cell><cell>model monitoring</cell><cell>blind spots; timing;</cell><cell>scoring and</cell><cell>grading; extracting</cell><cell>frames with the</cell><cell>highest confidence</cell><cell>Colonoscopy images Timing; safe, alarm,</cell><cell>and dangerous</cell><cell>ranges of</cell><cell>withdrawal speed</cell><cell>for real-time</cell><cell>monitoring;</cell><cell>slipping warning</cell><cell></cell><cell>Colonoscopy images The probability of</cell><cell>polyps in each</cell><cell>frame; lesions</cell><cell>alarming</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Tool</cell><cell>function</cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Assistive</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Algorithms</cell><cell></cell><cell></cell><cell>DCNN (VGG-</cell><cell>16)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>DCNN</cell><cell>(ImageNet)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>DCNN</cell><cell>(AlexNet,</cell><cell>ZFNet,</cell><cell>YOLO V2)</cell><cell></cell><cell></cell><cell></cell><cell>Deep</cell><cell>learning</cell><cell>architecture</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>DCNN (VGG-</cell><cell>16 and</cell><cell>DenseNet)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>DCNN and</cell><cell>perceptual</cell><cell>hash</cell><cell>algorithms</cell><cell>(VGG-16)</cell><cell></cell><cell></cell><cell></cell><cell>DCNN-3D</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Control</cell><cell></cell><cell></cell><cell>Routine EGD</cell><cell>examination</cell><cell>stratified by</cell><cell>three types</cell><cell>without AI</cell><cell></cell><cell></cell><cell>Regular</cell><cell>ophthalmic</cell><cell>diagnosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopies</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopies</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine EGD</cell><cell>examination</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Tools for</cell><cell>intervention</cell><cell></cell><cell>Routine EGD</cell><cell>examination</cell><cell>stratified by three</cell><cell>types with the</cell><cell>assistance of</cell><cell>ENDOANGEL</cell><cell>AI system</cell><cell>CC-cruiser web</cell><cell>diagnosis platform</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopies</cell><cell>with the assistance</cell><cell>of an AI automatic</cell><cell>quality</cell><cell>control system</cell><cell></cell><cell>Routine</cell><cell>colonoscopies</cell><cell>with the assistance</cell><cell>of an automatic</cell><cell>polyp</cell><cell>detection system</cell><cell></cell><cell>Routine EGD</cell><cell>examination with</cell><cell>the assistance of</cell><cell>WISENSE AI system</cell><cell></cell><cell></cell><cell></cell><cell>ENDOANGEL-</cell><cell>assisted routine</cell><cell>colonoscopy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Routine</cell><cell>colonoscopy with</cell><cell>CADe assistance</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Sample size</cell><cell></cell><cell></cell><cell>437</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>700</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>659</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1058</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>303</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>704</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1026</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Conditions</cell><cell></cell><cell></cell><cell>Upper</cell><cell>gastrointestinal</cell><cell>lesions</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Childhood</cell><cell>cataracts</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Colorectal cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Colorectal cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Upper</cell><cell>gastrointestinal</cell><cell>lesions</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Colorectal cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Colorectal cancer</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Reference</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Liu</cell><cell>(2020) 42</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_JMqJMTD"><s xml:id="_ujFjaYp">Comparisons among trials involving traditional statistical, machine learning and deep learning predictive tool interventions.</s></p></div></figDesc><table><row><cell>Variables</cell><cell>Levels</cell><cell>TS (n = 37)</cell><cell>ML (n = 17)</cell><cell>DL (n = 11)</cell><cell>P value</cell></row><row><cell cols="2">Duration of study (n = 59, months, median [IQR])</cell><cell>17 [8, 32]</cell><cell>7 [4, 19]</cell><cell>6 [4, 9]</cell><cell>0.005</cell></row><row><cell>Sample size (median [IQR])</cell><cell></cell><cell>435 [194, 999]</cell><cell>258 [90, 537]</cell><cell>700 [548, 994]</cell><cell>0.122</cell></row><row><cell>Clinical settings (%)</cell><cell>Outpatients</cell><cell>19 (51.4)</cell><cell>6 (35.3)</cell><cell>1 (9.1)</cell><cell>0.015</cell></row><row><cell></cell><cell>Inpatients</cell><cell>17 (45.9)</cell><cell>8 (47.1)</cell><cell>10 (90.9)</cell><cell></cell></row><row><cell></cell><cell>Home</cell><cell>1 (2.7)</cell><cell>3 (17.6)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell>Publication year (%)</cell><cell>2010-2015</cell><cell>14 (37.8)</cell><cell>7 (41.2)</cell><cell>0 (0.0)</cell><cell>0.041</cell></row><row><cell></cell><cell>2016-2020</cell><cell>23 (62.2)</cell><cell>10 (58.8)</cell><cell>11 (100.0)</cell><cell></cell></row><row><cell>Model input (%)</cell><cell>Clinical quantitative data</cell><cell>36 (97.3)</cell><cell>16 (94.1)</cell><cell>0 (0.0)</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>Images or videos</cell><cell>1 (2.7)</cell><cell>0 (0.0)</cell><cell>10 (90.9)</cell><cell></cell></row><row><cell></cell><cell>Natural language</cell><cell>0 (0.0)</cell><cell>1 (5.9)</cell><cell>1 (9.1)</cell><cell></cell></row><row><cell>Disease category (%)</cell><cell>Cancer</cell><cell>2 (5.4)</cell><cell>0 (0.0)</cell><cell>9 (81.8)</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>Chronic disease</cell><cell>4 (10.8)</cell><cell>13 (76.5)</cell><cell>1 (9.1)</cell><cell></cell></row><row><cell></cell><cell>Acute disease</cell><cell>16 (43.2)</cell><cell>2 (11.8)</cell><cell>1 (9.1)</cell><cell></cell></row><row><cell></cell><cell>Primary care</cell><cell>9 (24.3)</cell><cell>0 (0.0)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell></cell><cell>Others</cell><cell>6 (16.2)</cell><cell>2 (11.8)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell cols="2">Prediction tools function (%) Assistive diagnosis</cell><cell>3 (8.1)</cell><cell>2 (11.8)</cell><cell>11 (100.0)</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>Risk stratification</cell><cell>11 (29.7)</cell><cell>1 (5.9)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell></cell><cell cols="2">Assistive treatment decision 22 (59.5)</cell><cell>13 (76.5)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell></cell><cell>Others</cell><cell>1 (2.7)</cell><cell>1 (5.9)</cell><cell>0 (0.0)</cell><cell></cell></row><row><cell>Results (%)</cell><cell>Negative</cell><cell>18 (48.6)</cell><cell>5 (29.4)</cell><cell>2 (18.2)</cell><cell>0.136</cell></row><row><cell></cell><cell>Positive</cell><cell>19 (51.4)</cell><cell>12 (70.6)</cell><cell>9 (81.8)</cell><cell>0.044 (P for trend)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_KvwCxwE"><s xml:id="_WwAbbPS">npj Digital Medicine (2021) 154 Published in partnership with Seoul National University Bundang Hospital 1234567890():,;</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_VdXVgE6"><s xml:id="_9p7v3M8">Published in partnership with Seoul National University Bundang Hospital npj Digital Medicine (2021) 154</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_Pq3rqMC"><s xml:id="_QK6pVge">npj Digital Medicine (2021) 154Published in partnership with Seoul National University Bundang Hospital</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_WBuEynz">ACKNOWLEDGEMENTS</head><p xml:id="_PnzKW2Q"><s xml:id="_gkkepmW">This study was funded by the <rs type="funder">Medical Scientific Research Foundation of Guangdong Province of China</rs> (grant number <rs type="grantNumber">A2019489</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_MACAbUm">
					<idno type="grant-number">A2019489</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6y6j7Bc">DATA AVAILABILITY</head><p xml:id="_hdWqfC3"><s xml:id="_GEQr9qQ">The data that support the findings of this study are available on reasonable request from the authors.</s><s xml:id="_xtZpYYA">A full list of records identified through database searching are included in the supplementary information.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_w9xRGpu">CODE AVAILABILITY</head><p xml:id="_9gC8sCs"><s xml:id="_7upycaf">The codes of the paper are available on reasonable request from the authors.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8N9JZXD">AUTHOR CONTRIBUTIONS</head><p xml:id="_Yujw9dF"><s xml:id="_TxTWMv5">Q.Z.: conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; software; supervision; roles/writingoriginal draft.</s><s xml:id="_RZ7DCWm">Z.-h.C.: data curation; methodology; writing-review and editing.</s><s xml:id="_8mTA8zu">Y.-h.C.: data curation; formal analysis; methodology; software; writing-review and editing.</s><s xml:id="_qgkqHNM">S.P.: writing-review and editing.</s><s xml:id="_VkU6Aa4">Q.Z. and Z.h.C. were co-first authors to this work.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4GWqwAM">COMPETING INTERESTS</head><p xml:id="_WNp4n9n"><s xml:id="_DKS9zG7">The authors declare no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8tCpTKt">ADDITIONAL INFORMATION Supplementary information</head><p xml:id="_FV9rJUW"><s xml:id="_TbjqjEn">The online version contains supplementary material available at <ref type="url" target="https://doi.org/10.1038/s41746-021-00524-2">https://doi.org/10.1038/s41746-021-00524-2</ref>.</s></p><p xml:id="_X6P66re"><s xml:id="_8U94BVt">Correspondence and requests for materials should be addressed to Qian Zhou.</s></p><p xml:id="_bgqfH33"><s xml:id="_vaqsHkb">Reprints and permission information is available at <ref type="url" target="http://www.nature.com/reprints">http://www.nature.com/  reprints</ref> Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_ukpqW2g">Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Reitsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Moons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eVsaN9z">BMJ</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page">7594</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Collins, G. S., Reitsma, J. B., Altman, D. G. &amp; Moons, K. G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350, g7594 (2015).</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_swekEqA">Prediction models-development, evaluation, and clinical application</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pencina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>D'agostino</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmp2000589</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VFppxAh">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="1583" to="1586" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pencina, M. J., Goldstein, B. A. &amp; D&apos;Agostino, R. B. Prediction models-development, evaluation, and clinical application. N. Engl. J. Med 382, 1583-1586 (2020).</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_9QJwCj8">Prediction models need appropriate internal, internal-external, and external validation</title>
		<author>
			<persName><forename type="first">E</forename><surname>Steyerberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Harrell</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_St4Y3dr">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="245" to="247" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steyerberg, E. &amp; Harrell, F. E. Jr. Prediction models need appropriate internal, internal-external, and external validation. J. Clin. Epidemiol. 69, 245-247 (2016).</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_SZ4cZ7c">A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Eagle</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.accreview.2004.07.119</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GX4zn5s">Jama</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="2727" to="2733" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eagle, K. A. et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. Jama 291, 2727-2733 (2004).</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_8SjvZRj">Prediction of coronary heart disease using risk factor categories</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_afgYdAD">Circulation</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1837" to="1847" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilson, P. W. et al. Prediction of coronary heart disease using risk factor cate- gories. Circulation 97, 1837-1847 (1998).</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_ajkBR94">Artificial intelligence and machine learning in clinical development: a translational perspective</title>
		<author>
			<persName><forename type="first">P</forename><surname>Shah</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41746-019-0148-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v4kg43a">NPJ Digit. Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">69</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shah, P. et al. Artificial intelligence and machine learning in clinical development: a translational perspective. NPJ Digit. Med. 2, 69 (2019).</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_FdgpG2C">Machine learning in GI endoscopy: practical guidance in how to interpret a novel field</title>
		<author>
			<persName><forename type="first">F</forename><surname>Van Der Sommen</surname></persName>
		</author>
		<idno type="DOI">10.1136/gutjnl-2019-320466</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TwwgtSv">Gut</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="2035" to="2045" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van der Sommen, F. et al. Machine learning in GI endoscopy: practical guidance in how to interpret a novel field. Gut 69, 2035-2045 (2020).</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_WZQUdYD">Application of artificial intelligence to gastroenterology and hepatology</title>
		<author>
			<persName><forename type="first">C</forename><surname>Le Berre</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.gastro.2019.08.058</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GVfkzky">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page">72</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Le Berre, C. et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology 158, 76-94.e72 (2019).</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_n9g3HD5">Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sollini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Antunovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kirienko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WegVe8r">Eur. J. Nucl. Med. Mol. Imaging</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="2656" to="2672" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sollini, M., Antunovic, L., Chiti, A. &amp; Kirienko, M. Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics. Eur. J. Nucl. Med. Mol. Imaging 46, 2656-2672 (2019).</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_ZrwfEqb">Global trend in artificial intelligence-based publications in radiology from 2000 to 2018</title>
		<author>
			<persName><forename type="first">E</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mutasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N9JJAdA">AJR Am. J. Roentgenol</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope unit="page" from="1204" to="1206" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">West, E., Mutasa, S., Zhu, Z. &amp; Ha, R. Global trend in artificial intelligence-based publications in radiology from 2000 to 2018. AJR Am. J. Roentgenol. 213, 1204-1206 (2019).</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_F5fFpKv">Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nagendran</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.m689</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JA4wGZp">BMJ</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page">689</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nagendran, M. et al. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ 368, m689 (2020).</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_eCN7BPU">Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness</title>
		<author>
			<persName><forename type="first">S</forename><surname>Vollmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ttydhba">BMJ</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page">6927</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vollmer, S. et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effective- ness. BMJ 368, l6927 (2020).</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_y8WaP2R">A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Stafford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FP2x3Xv">NPJ Digit. Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">30</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stafford, I. S. et al. A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases. NPJ Digit. Med. 3, 30 (2020).</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_aN3bQPw">Machine learning improves mortality risk prediction after cardiac surgery: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">U</forename><surname>Benedetto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jtcvs.2020.07.105</idno>
		<ptr target="https://doi.org/10.1016/j.jtcvs.2020.07.105" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_NtXtZpw">J. Thoracic Cardiovasc. Surg</title>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benedetto, U. et al. Machine learning improves mortality risk prediction after cardiac surgery: systematic review and meta-analysis. J. Thoracic Cardiovasc. Surg. https://doi.org/10.1016/j.jtcvs.2020.07.105 (2020).</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_YmstxJH">Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P8gcEHN">ESC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="106" to="115" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shin, S. et al. Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality. ESC Heart Fail. 8, 106-115 (2021).</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_UbzEWzU">Validation of a machine learning model that outperforms clinical risk scoring systems for upper gastrointestinal bleeding</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Shung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kNYs3wf">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="160" to="167" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shung, D. L. et al. Validation of a machine learning model that outperforms clinical risk scoring systems for upper gastrointestinal bleeding. Gastroenterology 158, 160-167 (2020).</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_eFwRU2g">Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ytwrUhJ">J. Hepatol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="1133" to="1144" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Xu, X. et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J. Hepatol. 70, 1133-1144 (2019).</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_vM6W7cn">Deep learning encodes robust discriminative neuroimaging representations to outperform standard machine learning</title>
		<author>
			<persName><forename type="first">A</forename><surname>Abrol</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41467-020-20655-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vz9HyH8">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">353</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abrol, A. et al. Deep learning encodes robust discriminative neuroimaging repre- sentations to outperform standard machine learning. Nat. Commun. 12, 353 (2021).</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_Jv2cEmM">Different scaling of linear models and deep learning in UKBiobank brain images versus machine-learning datasets</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schulz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bcP8jNB">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">4238</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schulz, M. A. et al. Different scaling of linear models and deep learning in UKBiobank brain images versus machine-learning datasets. Nat. Commun. 11, 4238 (2020).</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_VZ8pkcU">Dermatologist-level classification of skin cancer with deep neural networks</title>
		<author>
			<persName><forename type="first">A</forename><surname>Esteva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cKQRCkJ">Nature</title>
		<imprint>
			<biblScope unit="volume">542</biblScope>
			<biblScope unit="page" from="115" to="118" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115-118 (2017).</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_HSEvJan">Deep learning</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lecun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bengio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hinton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AmRrHgn">Nature</title>
		<imprint>
			<biblScope unit="volume">521</biblScope>
			<biblScope unit="page" from="436" to="444" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">LeCun, Y., Bengio, Y. &amp; Hinton, G. Deep learning. Nature 521, 436-444 (2015).</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_TNw4Cwj">A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models</title>
		<author>
			<persName><forename type="first">E</forename><surname>Christodoulou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dYWZBxe">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="12" to="22" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christodoulou, E. et al. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J. Clin. Epidemiol. 110, 12-22 (2019).</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_quUVJQE">Logistic regression and machine learning predicted patient mortality from large sets of diagnosis codes comparably</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Cowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Cromwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bellot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Sharples</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Der Meulen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2020.12.018</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M88xVkP">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="43" to="52" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cowling, T. E., Cromwell, D. A., Bellot, A., Sharples, L. D. &amp; van der Meulen, J. Logistic regression and machine learning predicted patient mortality from large sets of diagnosis codes comparably. J. Clin. Epidemiol. 133, 43-52 (2021).</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_zhaAgSv">Complex machine-learning algorithms and multivariable logistic regression on par in the prediction of insufficient clinical response to methotrexate in rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Gosselt</surname></persName>
		</author>
		<idno type="DOI">10.3390/jpm11010044</idno>
		<ptr target="https://doi.org/10.3390/jpm11010044" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_c83R9hA">J. Pers. Med</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gosselt, H. R. et al. Complex machine-learning algorithms and multivariable logistic regression on par in the prediction of insufficient clinical response to methotrexate in rheumatoid arthritis. J. Pers. Med. https://doi.org/10.3390/ jpm11010044 (2021).</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_V7xtF47">Standard machine learning approaches outperform deep representation learning on phenotype prediction from transcriptomics data</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12859-020-3427-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VsEycTW">BMC Bioinform</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">119</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith, A. M. et al. Standard machine learning approaches outperform deep representation learning on phenotype prediction from transcriptomics data. BMC Bioinform. 21, 119 (2020).</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_VdpuVJK">Risk prediction models: II. External validation, model updating, and impact assessment</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Moons</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2011-301247</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pdTawpS">Heart</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="691" to="698" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moons, K. G. et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98, 691-698 (2012).</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_PpajEYv">Evaluating the impact of prediction models: lessons learned, challenges, and recommendations</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Kappen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fYJaVF4">Diagnostic Prognostic Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kappen, T. H. et al. Evaluating the impact of prediction models: lessons learned, challenges, and recommendations. Diagnostic Prognostic Res. 2, 11 (2018).</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_9A5QfDX">Prognosis and prognostic research: application and impact of prognostic models in clinical practice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Moons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Vergouwe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Royston</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.b606</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BEm84bN">BMJ</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page">606</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moons, K. G., Altman, D. G., Vergouwe, Y. &amp; Royston, P. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338, b606 (2009).</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_AAzNrdC">Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">X</forename><surname>Garg</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.293.10.1223</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DHEwGcF">Jama</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="1223" to="1238" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garg, A. X. et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. Jama 293, 1223-1238 (2005).</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_ypCD8Bp">Validation, updating and impact of clinical prediction rules: a review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Toll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Vergouwe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Moons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WTdzD9B">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1085" to="1094" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Toll, D. B., Janssen, K. J., Vergouwe, Y. &amp; Moons, K. G. Validation, updating and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61, 1085-1094 (2008).</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_G4uTRjr">Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs)</title>
		<author>
			<persName><forename type="first">E</forename><surname>Wallace</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p7bWHa7">BMC Med. Inform. Decis. Mak</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">62</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wallace, E. et al. Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs). BMC Med. Inform. Decis. Mak. 11, 62 (2011).</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_ypaD5PJ">Assessing the gold standard-lessons from the history of RCTs</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Bothwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Greene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Podolsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Jones</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmms1604593</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KUg7ZVf">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page" from="2175" to="2181" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bothwell, L. E., Greene, J. A., Podolsky, S. H. &amp; Jones, D. S. Assessing the gold standard-lessons from the history of RCTs. N. Engl. J. Med. 374, 2175-2181 (2016).</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_9uNSpFs">A web-based clinical decision support system for gestational diabetes: automatic diet prescription and detection of insulin needs</title>
		<author>
			<persName><forename type="first">E</forename><surname>Caballero-Ruiz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijmedinf.2017.02.014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R7nxgR2">Int. J. Med. Inform</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="35" to="49" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Caballero-Ruiz, E. et al. A web-based clinical decision support system for gesta- tional diabetes: automatic diet prescription and detection of insulin needs. Int. J. Med. Inform. 102, 35-49 (2017).</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_xFYYN3v">Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zbwSRHW">Lancet</title>
		<imprint>
			<biblScope unit="volume">389</biblScope>
			<biblScope unit="page" from="1719" to="1729" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Group, I. C. Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial. Lancet 389, 1719-1729 (2017).</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_RkBmxNr">Impact of a collective intelligence tailored messaging system on smoking cessation: the perspect randomized experiment</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Sadasivam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Borglund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Marlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Houston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7nq9NTe">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">285</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sadasivam, R. S., Borglund, E. M., Adams, R., Marlin, B. M. &amp; Houston, T. K. Impact of a collective intelligence tailored messaging system on smoking cessation: the perspect randomized experiment. J. Med. Internet Res. 18, e285 (2016).</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_dN3bHGP">Personalized nutrition by prediction of glycemic responses</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zeevi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EnZqz7n">Cell</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="1079" to="1094" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094 (2015).</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_VF36dCu">A conceptual framework for prognostic research</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cancelliere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Cassidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kongsted</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12874-020-01050-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_84qK7NQ">BMC Med. Res. Methodol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">172</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kent, P., Cancelliere, C., Boyle, E., Cassidy, J. D. &amp; Kongsted, A. A conceptual framework for prognostic research. BMC Med. Res. Methodol. 20, 172 (2020).</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_S4nvPjW">Investigating the use of data-driven artificial intelligence in computerised decision support systems for health and social care: a systematic review</title>
		<author>
			<persName><forename type="first">K</forename><surname>Cresswell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pJ5FAvy">Health Inform. J</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2138" to="2147" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cresswell, K. et al. Investigating the use of data-driven artificial intelligence in computerised decision support systems for health and social care: a systematic review. Health Inform. J. 26, 2138-2147 (2020).</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_BX5Xhen">Applications of machine learning in real-life digital health interventions: review of the literature</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Triantafyllidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tsanas</surname></persName>
		</author>
		<idno type="DOI">10.2196/12286</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nYMzBwm">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">12286</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Triantafyllidis, A. K. &amp; Tsanas, A. Applications of machine learning in real-life digital health interventions: review of the literature. J. Med. Internet Res. 21, e12286 (2019).</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_jJrVrXg">Statement: updated guidelines for reporting parallel group randomised trials</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><surname>Consort</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2010.02.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MKCX3Za">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="834" to="840" />
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schulz, K. F., Altman, D. G. &amp; Moher, D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J. Clin. Epidemiol. 63, 834-840 (2010).</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_aaWyYBe">Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Consort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-A</forename><forename type="middle">S</forename><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GGEZApw">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1467" to="1468" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Consort, A. I. &amp; Group, S.-A. S. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat. Med. 25, 1467-1468 (2019).</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_26NvkrH">Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension</title>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cruz Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Calvert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Denniston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rwnvnbG">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1364" to="1374" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J. &amp; Denniston, A. K. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364-1374 (2020).</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_5mv2zgE">The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.d5928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NrqfUgv">BMJ</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">5928</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins, J. P. et al. The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_HEb4hfJ">Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Geersing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7jbfMqe">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">32844</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geersing, G. J. et al. Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS ONE 7, e32844 (2012).</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_RRb4Fnz">The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration</title>
		<author>
			<persName><forename type="first">A</forename><surname>Liberati</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.b2700</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mxRXQbn">BMJ</title>
		<imprint>
			<biblScope unit="volume">339</biblScope>
			<biblScope unit="page">2700</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009).</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_Gb7QjvE">Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Reitsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Moons</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2014.11.010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_C5Kb6A5">J. Clin. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="134" to="143" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Collins, G. S., Reitsma, J. B., Altman, D. G. &amp; Moons, K. G. Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. J. Clin. Epidemiol. 68, 134-143 (2015).</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_xRuZk2r">Epidemiology and reporting of randomised trials published in PubMed journals</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(05)71879-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Zxcvx5P">Lancet</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="1159" to="1162" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chan, A. W. &amp; Altman, D. G. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365, 1159-1162 (2005).</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_WzT5hpr">The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hopewell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Cszgq2M">PubMed. Bmj</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page">723</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hopewell, S., Dutton, S., Yu, L. M., Chan, A. &amp; Altman, D. G. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. Bmj 340, c723 (2010).</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_RSwr3cV">Real-world evidence-what is it and what can it tell us?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Sherman</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmsb1609216</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gJwCXgX">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="page" from="2293" to="2297" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sherman, R. E. et al. Real-world evidence-what is it and what can it tell us? N. Engl. J. Med. 375, 2293-2297 (2016).</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_ZvDv8b4">Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WqTm8Rj">Eur. J. Nucl. Med. Mol. Imaging</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="2812" to="2813" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou, Q., Cao, Y. H. &amp; Chen, Z. H. Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings. Eur. J. Nucl. Med. Mol. Imaging 46, 2812-2813 (2019).</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_SWuUB7x">Risk model-guided antiemetic prophylaxis vs physician&apos;s choice in patients receiving chemotherapy for early-stage breast cancer: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Clemons</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamaoncol.2015.3730</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hh8sTnE">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="225" to="231" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Clemons, M. et al. Risk model-guided antiemetic prophylaxis vs physician&apos;s choice in patients receiving chemotherapy for early-stage breast cancer: a randomized clinical trial. JAMA Oncol. 2, 225-231 (2016).</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_pwe7bB6">Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Guenancia</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00380-015-0695-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xjTPe4A">Heart Vessels</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="897" to="906" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guenancia, C. et al. Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study. Heart Vessels 31, 897-906 (2016).</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_fnKDykE">Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EEh9CtF">Lancet</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="1560" to="1571" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hill, J. C. et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet 378, 1560-1571 (2011).</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_xnRAYZF">Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Geersing</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1003142</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kYYrVRy">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">1003142</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geersing, G. J. et al. Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous throm- boembolism compared to usual care: a randomized controlled trial. PLoS Med. 17, e1003142 (2020).</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_WBGMyjn">Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: a stepped-wedge cluster randomized clinical trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Manz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R76RUZJ">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">204759</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Manz, C. R. et al. Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: a stepped-wedge cluster randomized clinical trial. JAMA Oncol. 6, e204759 (2020).</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_9uTtHQt">A randomized control trial using a validated prediction model for diagnosing acute heart failure in undifferentiated dyspneic emergency department patients-results of the GASP4Ar Study</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Steinhart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FpvwHpW">J. Card. Fail</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="145" to="152" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steinhart, B. D. et al. A randomized control trial using a validated prediction model for diagnosing acute heart failure in undifferentiated dyspneic emergency department patients-results of the GASP4Ar Study. J. Card. Fail. 23, 145-152 (2016).</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_Xsmdpup">Design and analysis of stepped wedge cluster randomized trials</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hussey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hughes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PsjgEYw">Contemp. Clin. Trials</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="182" to="191" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hussey, M. A. &amp; Hughes, J. P. Design and analysis of stepped wedge cluster randomized trials. Contemp. Clin. Trials 28, 182-191 (2007).</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_kvWt6JZ">Effect of machine learning on dispatcher recognition of outof-hospital cardiac arrest during calls to emergency medical services: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Blomberg</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2020.32320</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g39b9A8">JAMA Netw. Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2032320</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Blomberg, S. N. et al. Effect of machine learning on dispatcher recognition of out- of-hospital cardiac arrest during calls to emergency medical services: a rando- mized clinical trial. JAMA Netw. Open 4, e2032320 (2021).</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_h5RDZcQ">Randomized trial of model predictive control for improved anemia management</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Brier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Gaweda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Aronoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Jacobs</surname></persName>
		</author>
		<idno type="DOI">10.2215/cjn.07181009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_z2WZMXj">Clin. J. Am. Soc. Nephrol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="814" to="820" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brier, M. E., Gaweda, A. E., Dailey, A., Aronoff, G. R. &amp; Jacobs, A. A. Randomized trial of model predictive control for improved anemia management. Clin. J. Am. Soc. Nephrol. 5, 814-820 (2010).</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_yhFUarG">A randomized controlled trial comparing health and quality of life of lung transplant recipients following nurse and computer-based triage utilizing home spirometry monitoring</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Finkelstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pjgVh6z">Telemed. J. e-Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="897" to="903" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Finkelstein, S. M. et al. A randomized controlled trial comparing health and quality of life of lung transplant recipients following nurse and computer-based triage utilizing home spirometry monitoring. Telemed. J. e-Health. 19, 897-903 (2013).</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_QyZrfnQ">Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vSz32Be">Lancet Gastroenterol. Hepatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="343" to="351" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang, P. et al. Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind rando- mised study. Lancet Gastroenterol. Hepatol. 5, 343-351 (2020).</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_kHZ4YCw">Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Repici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2RvrkFU">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page">517</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Repici, A. et al. Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial. Gastroenterology 159, 512-520.e517 (2020).</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_9fZ6H67">The impact of deep convolutional neural network-based artificial intelligence on colonoscopy outcomes: a systematic review with meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aziz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fatima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lee-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nawras</surname></persName>
		</author>
		<idno type="DOI">10.1111/jgh.15070</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cGRbRw9">J. Gastroenterol. Hepatol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1676" to="1683" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Aziz, M., Fatima, R., Dong, C., Lee-Smith, W. &amp; Nawras, A. The impact of deep convolutional neural network-based artificial intelligence on colonoscopy out- comes: a systematic review with meta-analysis. J. Gastroenterol. Hepatol. 35, 1676-1683 (2020).</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_7BGXh5M">A trial of a real-time alert for clinical deterioration in patients hospitalized on general medical wards</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Bailey</surname></persName>
		</author>
		<idno type="DOI">10.1002/jhm.2009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_remnV3P">J. Hosp. Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="236" to="242" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bailey, T. C. et al. A trial of a real-time alert for clinical deterioration in patients hospitalized on general medical wards. J. Hosp. Med. 8, 236-242 (2013).</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
